# Quantum Molecular Resonance Effects on Patients With Dry Eye Disease

> **NCT05469932** · NA · UNKNOWN · sponsor: **Assaf-Harofeh Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DEVICE:** Rexon device

## Key facts

- **NCT ID:** NCT05469932
- **Lead sponsor:** Assaf-Harofeh Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-02-14
- **Primary completion:** 2022-12
- **Final completion:** 2022-12
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2022-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05469932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05469932, "Quantum Molecular Resonance Effects on Patients With Dry Eye Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05469932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*